Literature DB >> 21443660

Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.

Taro Yamashita1, Masao Honda, Shuichi Kaneko.   

Abstract

Hepatitis C virus (HCV) infection is a major cause of hepatocellular carcinoma (HCC) and chronic liver disease worldwide. Recent developments and advances in HCV replication systems in vitro and in vivo, transgenic animal models, and gene expression profiling approaches have provided novel insights into the mechanisms of HCV replication. They have also helped elucidate host cellular responses, including activated/inactivated signaling pathways, and the relationship between innate immune responses by HCV infection and host genetic traits. However, the mechanisms of hepatocyte malignant transformation induced by HCV infection are still largely unclear, most likely due to the heterogeneity of molecular paths leading to HCC development in each individual. In this review, we summarize recent advances in knowledge about the mechanisms of hepatocarcinogenesis induced by HCV infection.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21443660     DOI: 10.1111/j.1440-1746.2011.06723.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.

Authors:  Yo-Ichi Yamashita; Katsunori Imai; Takayoshi Kaida; Takanobu Yamao; Masayo Tsukamoto; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Takatoshi Ishiko; Tomoharu Yoshizumi; Tetsuo Ikeda; Yoshihiko Maehara; Hideo Baba
Journal:  Surg Endosc       Date:  2018-06-05       Impact factor: 4.584

2.  A rapid, low-cost quantitative diagnostic method for hepatitis C virus infection using capillary zone electrophoresis.

Authors:  A M Attallah; S O Abdallah; M A El-Desouky; M El-Far; M M Omran; K Farid; M A Abdelrazek; M N Shabaka; H Zaghloul; A M Fawzy; F B Bazeed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-20       Impact factor: 3.267

3.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

4.  Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.

Authors:  Abdel-Rahman Nabawy Zekri; Amira Salah El-Din Youssef; Yasser Mabrouk Bakr; Reham Mohamed Gabr; Ola Sayed Ahmed; Mostafa Hamed Elberry; Ahmed Mahmoud Mayla; Mohamed Abouelhoda; Abeer A Bahnassy
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 5.  Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?

Authors:  Youngmin A Lee; Scott L Friedman
Journal:  Antiviral Res       Date:  2014-04-12       Impact factor: 5.970

Review 6.  Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance.

Authors:  Katsuhisa Nakatsuka; Masanori Atsukawa; Masumi Shimizu; Hidemi Takahashi; Chiaki Kawamoto
Journal:  World J Hepatol       Date:  2015-11-08

7.  Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Liver.

Authors:  Yoshiaki Shimizu; Kuniaki Arai; Taro Yamashita; Tatsuya Yamashita; Tetsuro Shimakami; Kazunori Kawaguchi; Kazuya Kitamura; Yoshio Sakai; Eishiro Mizukoshi; Masao Honda; Azusa Kitao; Kazuto Kozaka; Satoshi Kobayashi; Shuichi Kaneko
Journal:  Liver Cancer       Date:  2020-01-07       Impact factor: 11.740

8.  Chimeric mouse model for the infection of hepatitis B and C viruses.

Authors:  Abeba Tesfaye; Judith Stift; Dragan Maric; Qingwen Cui; Hans-Peter Dienes; Stephen M Feinstone
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  Different faces of hepatocellular carcinoma as a health threat in 21st century.

Authors:  Behzad Yeganeh; Mohammad Hashemi; Fredrick J de Serres; Marek J Los; Saeid Ghavami
Journal:  Hepat Mon       Date:  2013-02-04       Impact factor: 0.660

10.  Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.

Authors:  Ricardo C Gehrau; Kellie J Archer; Valeria R Mas; Daniel G Maluf
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.